2 months Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha X
2 months Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily X
2 months Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC X
2 months Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha X
2 months Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com X
2 months Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily X
2 months Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC X
2 months AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily X
2 months Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion Yahoo Finance X
2 months These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More Yahoo Finance X
2 months Pfizer: Lowest Levels In A Decade Is An Opportunity With A Dividend Yield Exceeding 6.5% Seeking Alpha X
2 months Amazon, Pfizer execs seek common ground with RFK Jr on climate risks to health Investing.com X
3 months Pfizer’s New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments Yahoo Finance X
3 months Mastercard, Broadcom, Pfizer Among Two Dozen Companies To Announce Dividend Increases In December Seeking Alpha X
3 months Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead? Yahoo Finance X
3 months BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer’s Heart Drug Investor's Business Daily X
Stock Market News